CANNASOUTH LTD NPVCANNASOUTH LTD NPVCANNASOUTH LTD NPV

CANNASOUTH LTD NPV

No trades
See on Supercharts

CBD fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. It focuses on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. The company's products include sprays, tablets, patches, topicals, softgels and tinctures. Cannasouth was founded by Mark Lucas and Nic Foreman on August 21, 2018 and is headquartered in Hamilton, New Zealand.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CBD does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company